Viral load and disease severity in COVID-19.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
03 2022
Historique:
received: 28 03 2021
accepted: 03 06 2021
pubmed: 17 6 2021
medline: 5 4 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

The relationship between COVID-19 severity and viral load is unknown. Our objective was to assess the association between viral load and disease severity in COVID-19. In this single center observational study of adults with laboratory confirmed SARS-CoV-2, the first positive in-hospital nasopharyngeal swab was used to calculate the log10 copies/ml [log10 copy number (CN)] of SARS-CoV-2. Four categories based on level of care and modified sequential organ failure assessment score (mSOFA) at time of swab were determined. Median log10CN was compared between different levels of care and mSOFA quartiles. Median log10CN was compared in patients who did and did not receive influenza vaccine, and the correlation between log10CN and D-dimer was examined. We found that of 396 patients, 54.3% were male, and 25% had no major comorbidity. Hospital mortality was 15.7%. Median mSOFA was 2 (IQR 0-3). Median log10CN was 5.5 (IQR 3.3-8.0). Median log10CN was highest in non-intubated ICU patients [6.4 (IQR 4.4-8.1)] and lowest in intubated ICU patients [3.6 (IQR 2.6-6.9)] (p value < 0.01). In adjusted analyses, this difference remained significant [mean difference 1.16 (95% CI 0.18-2.14)]. There was no significant difference in log10CN between other groups in the remaining pairwise comparisons. There was no association between median log10CN and mSOFA in either unadjusted or adjusted analyses or between median log10CN in patients with and without influenza immunization. There was no correlation between log10CN and D-dimer. We conclude, in our cohort, we did not find a clear association between viral load and disease severity in COVID-19 patients. Though viral load was higher in non-intubated ICU patients than in intubated ICU patients there were no other significant differences in viral load by disease severity.

Identifiants

pubmed: 34133005
doi: 10.1007/s11739-021-02786-w
pii: 10.1007/s11739-021-02786-w
pmc: PMC8206885
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

359-367

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL136705
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL127101
Pays : United States
Organisme : NIH HHS
ID : 1R03 AA026093
Pays : United States
Organisme : NIH HHS
ID : K24HL127101
Pays : United States
Organisme : NIH HHS
ID : R01HL136705
Pays : United States
Organisme : NIH HHS
ID : 1R01DK112886
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL128814
Pays : United States

Informations de copyright

© 2021. Società Italiana di Medicina Interna (SIMI).

Références

Clin Chem. 2020 Mar 10;:
pubmed: 32154877
Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
Ann Am Thorac Soc. 2021 May;18(5):900-903
pubmed: 33119425
Med Hypotheses. 2020 Apr 22;140:109752
pubmed: 32361099
J Gen Intern Med. 2021 Jun;36(6):1689-1695
pubmed: 33738759
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Antivir Ther. 2007;12(4):501-8
pubmed: 17668558
Wien Klin Wochenschr. 2021 Apr;133(7-8):406-411
pubmed: 33216213
Med J Aust. 2020 Jul;213(2):54-56.e1
pubmed: 32572965
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
BMJ. 2011 Mar 17;342:d1542
pubmed: 21415104
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
Nucleic Acids Res. 2008 Aug;36(14):e91
pubmed: 18603594
J Med Virol. 2001 Jul;64(3):262-8
pubmed: 11424113
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4931-4941
pubmed: 32075920
Clin Chim Acta. 2020 Nov;510:344-346
pubmed: 32712049
J Clin Invest. 1998 Feb 1;101(3):643-9
pubmed: 9449698
Crit Care. 2020 Apr 23;24(1):170
pubmed: 32326952
N Engl J Med. 2016 Oct 5;375(17):1638-1648
pubmed: 27705084
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9065-9
pubmed: 18550812
J Infect Dis. 2009 Aug 15;200(4):492-500
pubmed: 19591575
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Intensive Care. 2020 Jul 10;8:49
pubmed: 32665858
J Intensive Care. 2013 Oct 23;1(1):4
pubmed: 25705399
J Intensive Care Med. 2021 Oct;36(10):1217-1222
pubmed: 32799718
Am J Cardiovasc Drugs. 2020 Oct;20(5):393-403
pubmed: 32748336
Am J Pathol. 2020 Sep;190(9):1881-1887
pubmed: 32628931
BMJ. 2020 Apr 21;369:m1443
pubmed: 32317267
Cytokine Growth Factor Rev. 2020 Aug;54:62-75
pubmed: 32513566

Auteurs

Rahul Dnyaneshwar Pawar (RD)

Division of Hospital Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 1 Deaconess Road, Boston, MA, 02215, USA. rpawar@bidmc.harvard.edu.
Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. rpawar@bidmc.harvard.edu.

Lakshman Balaji (L)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Shivani Mehta (S)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Andrew Cole (A)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Xiaowen Liu (X)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Natia Peradze (N)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Anne Victoria Grossestreuer (AV)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Mahmoud Salah Issa (MS)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Parth Patel (P)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

James Edward Kirby (JE)

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Christopher Francis Rowley (CF)

Division of Infectious Disease, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Katherine Margaret Berg (KM)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Ari Moskowitz (A)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Michael William Donnino (MW)

Department of Emergency Medicine, Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH